Top news

View all

Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa

The advance purchase agreement (APA) will be funded by Gavi’s First Response Fund, a mechanism created after the COVID-19 pandemic to ensure rapid access to scarce vaccine supplies in future health emergencies.

15,000 mpox vaccine doses arrive in the Democratic Republic of the Congo

A shipment of 15,460 doses of mpox vaccine, donated to Gavi-eligible countries by the vaccine manufacturer Bavarian Nordic, arrived in the Democratic Republic of the Congo (DRC) today to support the global and regional effort to contain the…

Joint statement: UNICEF issues emergency tender to secure mpox vaccines for crisis-hit countries in collaboration with Africa CDC, Gavi and WHO

UNICEF today announced that it has issued an emergency tender for the procurement of mpox vaccines.

VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
 

Explore VaccinesWork

Nurse Madelein Semo vaccinates a young baby at the Ngbaka health centre in Kinshasa, Democratic Republic of the Congo. Credit: Gavi/Phil Moore

VaccinesWork latest

Armed with vaccine, families in Benin take the fight to malaria

215,900 doses of malaria vaccine began to roll out in Benin in April – and they’ve been welcomed with open arms, finds reporter Edna Fleure.

Antimicrobial resistance emerges as a bigger killer in Africa than malaria, HIV or TB

Antimicrobial resistance is a ‘silent pandemic’ threatening the lives of millions on the African continent, says new report.

Unravelling the history and mystery of Oropouche virus

Oropouche, or ‘sloth fever’, is the latest long-known but little-known virus escaping its usual habitat and spreading into new territory. What is this mysterious disease, and how can we stop it?

Vaccines support

Gavi supports vaccines against 20 infectious diseases, including COVID-19, Ebola, malaria and rabies. Learn more about our support for each vaccine by clicking below.

Visit page

Gavi supports vaccines against 20 infectious diseases, including COVID-19, Ebola, malaria and rabies. Learn more about our support for each vaccine by clicking below.

Visit page

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter